Prevalence of Adult Male Circumcision in the General Population and a Population at Increased Risk for HIV/AIDS in New York City

2008 ◽  
Vol 35 (9) ◽  
pp. 814-817 ◽  
Author(s):  
Christy M. McKinney ◽  
Ellen J. Klingler ◽  
Rachel Paneth-Pollak ◽  
Julia A. Schillinger ◽  
R Charon Gwynn ◽  
...  
2011 ◽  
Vol 71 (2) ◽  
pp. 243-252 ◽  
Author(s):  
Kimberley R. Isett ◽  
Michael Sparer ◽  
Sherry A. M. Glied ◽  
Lawrence D. Brown
Keyword(s):  
New York ◽  

2007 ◽  
Vol 122 (1_suppl) ◽  
pp. 4-6 ◽  
Author(s):  
Lucia V. Torian ◽  
Kelly J. Henning ◽  
Scott E. Kellerman ◽  
Thomas R. Frieden
Keyword(s):  
New York ◽  

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S99-S99
Author(s):  
Chaorui Huang ◽  
David Lucero ◽  
Denise Paone ◽  
Ellenie Tuazon ◽  
Demetre Daskalakis

Abstract Background Along with a growing opioid epidemic nationwide, opioid users often have an increased risk of severe infectious diseases including endocarditis, osteomyelitis, and central nervous system (CNS) abscess. As the largest city in the United States, New York City (NYC) may serve as a study model for opioid use and infectious diseases. We investigated the association between opioid use and hospitalizations for endocarditis, osteomyelitis, and CNS abscess in NYC. Methods Data for NYC residents aged ≥18 years discharged from New York State hospitals during 2001–2014 were analyzed using a hospital discharge dataset. We defined a hospitalization for endocarditis, osteomyelitis, and CNS abscess as one with a principal or secondary diagnosis for these conditions within the discharge record. We identified opioid users by examining principal or secondary diagnoses for opioid use within the discharge record at the time of hospitalization for endocarditis, osteomyelitis, and CNS abscess. Log-binomial model was applied among all hospitalized patients using endocarditis, osteomyelitis, and CNS abscess as the outcome, adjusting for age, sex, race, and borough. Results During 2001–2014, there were 139,392 hospitalizations in total for endocarditis, osteomyelitis, or CNS abscess, of which 8,823 (6.3%) were among opioid users. There was an increased risk of hospitalization for endocarditis [RR: 2.6 (95% CI: 2.5–2.7)], osteomyelitis [RR: 1.1 (95% CI: 1.1–1.1)], and CNS abscesses [RR: 1.9 (95% CI: 1.8–2.1)] among hospitalized opioid users compared with hospitalized nonopioid users, adjusted by age, sex, race, and borough. Hospitalized opioid users had four times the risk for endocarditis hospitalization compared with hospitalized nonopioid users in the 18–44 year age group (RR: 4.2 [95% CI: 3.9–4.5]) (Table 1). Conclusion These results provide further evidence that opioid use is associated with an increased risk of endocarditis, osteomyelitis, and CNS abscess. Efforts to combat the opioid epidemic might lower the overall incidence of endocarditis, osteomyelitis, and CNS abscess. Disclosures All authors: No reported disclosures.


2004 ◽  
Vol 9 (1-2) ◽  
pp. 109-124 ◽  
Author(s):  
Jennifer Ahern ◽  
Sandro Galea ◽  
Heidi Resnick ◽  
David Vlahov

Author(s):  
Angela Gomez-Simmonds ◽  
Medini K Annavajhala ◽  
Thomas H McConville ◽  
Donald E Dietz ◽  
Sherif M Shoucri ◽  
...  

Abstract Background Patients with COVID-19 may be at increased risk for secondary bacterial infections with MDR pathogens, including carbapenemase-producing Enterobacterales (CPE). Objectives We sought to rapidly investigate the clinical characteristics, population structure and mechanisms of resistance of CPE causing secondary infections in patients with COVID-19. Methods We retrospectively identified CPE clinical isolates collected from patients testing positive for SARS-CoV-2 between March and April 2020 at our medical centre in New York City. Available isolates underwent nanopore sequencing for rapid genotyping, antibiotic resistance gene detection and phylogenetic analysis. Results We identified 31 CPE isolates from 13 patients, including 27 Klebsiella pneumoniae and 4 Enterobacter cloacae complex isolates. Most patients (11/13) had a positive respiratory culture and 7/13 developed bacteraemia; treatment failure was common. Twenty isolates were available for WGS. Most K. pneumoniae (16/17) belonged to ST258 and encoded KPC (15 KPC-2; 1 KPC-3); one ST70 isolate encoded KPC-2. E. cloacae isolates belonged to ST270 and encoded NDM-1. Nanopore sequencing enabled identification of at least four distinct ST258 lineages in COVID-19 patients, which were validated by Illumina sequencing data. Conclusions While CPE prevalence has declined substantially in New York City in recent years, increased detection in patients with COVID-19 may signal a re-emergence of these highly resistant pathogens in the wake of the global pandemic. Increased surveillance and antimicrobial stewardship efforts, as well as identification of optimal treatment approaches for CPE, will be needed to mitigate their future impact.


1996 ◽  
Vol 15 (3) ◽  
pp. 250-260 ◽  
Author(s):  
Susan M. Chambre
Keyword(s):  
New York ◽  

2010 ◽  
Vol 24 (6) ◽  
pp. 373-380 ◽  
Author(s):  
Tiffany Floyd ◽  
Shilpa Patel ◽  
Elisa Weiss ◽  
Soye Zaid-Muhammad ◽  
David Lounsbury ◽  
...  

Author(s):  
Daniel Stadlbauer ◽  
Jessica Tan ◽  
Kaijun Jiang ◽  
Matthew M. Hernandez ◽  
Shelcie Fabre ◽  
...  

AbstractBy conducting a retrospective, cross-sectional analysis of SARS-CoV-2 seroprevalence in a ‘sentinel group’ (enriched for SARS-CoV-2 infections) and a ‘screening group’ (representative of the general population) using >5,000 plasma samples from patients at Mount Sinai Hospital in New York City (NYC), we identified seropositive samples as early as in the week ending February 23, 2020. A stark increase in seropositivity in the sentinel group started the week ending March 22 and in the screening group in the week ending March 29. By the week ending April 19, the seroprevalence in the screening group reached 19.3%, which is well below the estimated 67% needed to achieve community immunity to SARS-CoV-2. These data potentially suggest an earlier than previously documented introduction of SARS-CoV-2 into the NYC metropolitan area.One Sentence SummarySeroprevalence of SARS-CoV-2 in cross-sectional samples from New York City rose from 0% to 19.3% from early February to mid-April.


2021 ◽  
Vol 8 ◽  
Author(s):  
Annie Wang ◽  
Stephanie H. Chang ◽  
Eric J. Kim ◽  
Jamie L. Bessich ◽  
Joshua K. Sabari ◽  
...  

Management of patients with lung cancer continues to be challenging during the COVID-19 pandemic, due to the increased risk of complications in this subset of patients. During the COVID-19 surge in New York City, New York University Langone Health adopted triage strategies to help with care for lung cancer patients, with good surgical outcomes and no transmission of COVID-19 to patients or healthcare workers. Here, we will review current recommendations regarding screening and management of lung cancer patients during both a non-surge phase and surge phase of COVID-19.


Sign in / Sign up

Export Citation Format

Share Document